Introduction:Basic information about CAS 155415-08-0|Inogatran, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Inogatran |
|---|
| CAS Number | 155415-08-0 | Molecular Weight | 438.56400 |
|---|
| Density | 1.36g/cm3 | Boiling Point | / |
|---|
| Molecular Formula | C21H38N6O4 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | 2-[[(2R)-3-cyclohexyl-1-[(2S)-2-[3-(diaminomethylideneamino)propylcarbamoyl]piperidin-1-yl]-1-oxopropan-2-yl]amino]acetic acid |
|---|
| Synonym | More Synonyms |
|---|
Inogatran BiologicalActivity
| Description | Inogatran is a synthetic thrombin inhibitor, developed for the possible treatment and prophylaxis of arterial and venous thrombotic diseases. |
|---|
| Related Catalog | Signaling Pathways >>Metabolic Enzyme/Protease >>ThrombinResearch Areas >>Cardiovascular Disease |
|---|
| In Vivo | Inogatran (0.075, 0.25, 0.75 mg/kg, i.v.) results in dose-dependent increases in activated partial thromboplastin time (aPTT), thrombin time (TT), and prothrombin time (PT) in a canine electrolytic injury model of venous thrombosis[1]. Inogatran dose-dependently inhibits thrombus formation, which is measured as an increase in time to occlusion (TTO) and a decrease in thrombus weight. Inogatran also improves vena caval blood flow and reduces the overall incidence of thrombotic occlusion in a rat model[2]. |
|---|
| References | [1]. Ignasiak DP, et al. Effects of Intravenous Enoxaparin and Intravenous Inogatran in an Electrolytic Injury Model of Venous Thrombosis in the Dog. J Thromb Thrombolysis. 1998 Nov;6(3):199-206. [2]. Chi L, et al. Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatran. J Thromb Thrombolysis. 2001 Feb;11(1):19-31. |
|---|
Chemical & Physical Properties
| Density | 1.36g/cm3 |
|---|
| Molecular Formula | C21H38N6O4 |
|---|
| Molecular Weight | 438.56400 |
|---|
| Exact Mass | 438.29500 |
|---|
| PSA | 164.13000 |
|---|
| LogP | 2.73010 |
|---|
| Index of Refraction | 1.632 |
|---|
| InChIKey | CDPROXZBMHOBTQ-SJORKVTESA-N |
|---|
| SMILES | NC(N)=NCCCNC(=O)C1CCCCN1C(=O)C(CC1CCCCC1)NCC(=O)O |
|---|
| Storage condition | 2-8℃ |
|---|
Synonyms
| N-((1R)-2-Cyclohexyl-1-(((2S)-2-((3-guanidinopropyl)carbamoyl)piperidino)carbonyl)ethyl)glycine |
| Inogatran [INN] |
| {[(1R)-2-((2S)-2-{[(3-{[AMINO(IMINO)METHYL]AMINO}PROPYL)AMINO]CARBONYL}PIPERIDINYL)-1-(CYCLOHEXYLMETHYL)-2-OXOETHYL]AMINO}ACETIC ACID |
| IGN |
| Inogatran |